IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1607
Positioning
Market Dominance
Manufacturing
Printing And Publishing
$2.0B
Brian A. Napack
John Wiley & Sons, Inc. operates through three segments: Research Publishing, Academic & Professional Learning, and Education Services. The Research Publishing & Platforms segment offers scientific, technical, medical, and scholarly journals. The Education Services segment provides online program management services for higher education institutions.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = WLY ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$WLY JOHN WILEY & SONS, INC. | 53 | 73 | 85 | 26 | 21.2x | 11.1x | 10.0% | 3.0% | 74.2% | 13.2% | 4.3% | 4.4% | 3.8% | 118.0x | $2.0B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
JOHN WILEY & SONS, INC. (WLY) receives a "Hold" rating with a composite score of 52.5/100. It ranks #1607 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Brian A. Napack
Chief Executive Officer
Labor Force
9,500
73
31
78
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for WLY
Headcount
9.5K
HQ Base
Hoboken, New Jersey
Lagging peers — losers tend to keep underperforming
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for WLY.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
ROE proxy 10.0% (sector -2.5%)
GM 74% vs sector 43%, OM 13% vs sector 1%
Capital turnover N/A
Rev growth 4%, 11yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns JOHN WILEY & SONS, INC. a Hold rating, with a composite score of 52.5/100 and 3 out of 5 stars. Ranked #1607 of 7,333 stocks, WLY presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
WLY earns a quality score of 73/100, indicating above-average business quality. The company reports a return on equity of 10.0% (sector avg: -2.5%), gross margins of 74.2% (sector avg: 42.5%), net margins of 4.3% (sector avg: -0.2%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
WLY carries a solid value score of 85/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 21.19x, an EV/EBITDA of 11.10x, a P/B ratio of 2.12x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
JOHN WILEY & SONS, INC.'s investment score of 31/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 4.4% vs. a sector average of 5.9% and a return on assets of 3.0% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
JOHN WILEY & SONS, INC. is experiencing notably weak momentum with a score of just 26/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at 4.4% year-over-year, while a beta of 0.55 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
WLY shows good financial stability with a score of 78/100. Key stability metrics include a beta of 0.55 and a debt-to-equity ratio of 118.00x (sector avg: 0.2x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
JOHN WILEY & SONS, INC.'s short interest score of 24/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 118.00x), small-cap liquidity risk. At $2.0B (small-cap), WLY carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
WLY pays a solid dividend yield of 3.8%, contributing an income component to total returns. This moderate yield suggests a balance between returning capital to shareholders and retaining earnings for reinvestment — a common profile among quality compounders.
JOHN WILEY & SONS, INC. is a small-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #1607 of 7,333 overall (78th percentile). Key comparisons include ROE of 10.0% exceeding the -2.5% sector median and operating margins of 13.2% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While WLY currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Key factor gap
Value (85) vs Short Int. (24) — closing this gap could shift the rating.
EV/EBITDA IN LINE WITH SECTOR BENCHMARKS
ROE 504% BELOW SECTOR MEDIAN
Gross Margin 75% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF OCT 31, 2025 (Q3 FY2025)
We rate JOHN WILEY & SONS, INC. (WLY) as a Hold with a composite score of 52.5/100 at a current price of $29.34. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in value (85th percentile) and stability (78th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (26th percentile) and investment (31th percentile) tempers our overall conviction. We assign a No Moat rating (34/100), Medium uncertainty, and Standard capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; balance sheet deleveraging progress. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
JOHN WILEY & SONS, INC. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 52.5/100 places it at rank #1607 in our full 7,333-stock universe. At $2.0B in market capitalization, JOHN WILEY & SONS, INC. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 4%, though momentum at the 26th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 74% (+31.7pp vs sector) narrow to operating margins of 13% (+11.9pp vs sector) and net margins of 4.3%, yielding a gross-to-net conversion rate of 6%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $29.34, JOHN WILEY & SONS, INC. appears undervalued relative to its fundamentals. Our value factor score of 85/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 21.2x (roughly in line with the sector median of 22.3x), EV/EBITDA of 11.1x (near the sector median), P/B of 2.1x, P/S of 0.9x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Gross margins of 74% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
A value factor score of 85/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
A 3.84% dividend yield provides income while you wait, and dividends historically account for a significant portion of total equity returns.
Elevated leverage (118% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Weak momentum (26th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
We assign a Medium uncertainty rating to JOHN WILEY & SONS, INC.. The stock presents a balanced risk profile: significant leverage (118% debt-to-equity) and low beta of 0.55 — while defensive, this may indicate limited upside participation in bull markets. While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: significant leverage (118% debt-to-equity); low beta of 0.55 — while defensive, this may indicate limited upside participation in bull markets; the combination of leverage (118% D/E) and thin margins (4.3% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 78th percentile and quality factor at the 73th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 74% provide a buffer against cost pressures; above-average stability (78th percentile) suggests predictable business dynamics; a 3.84% dividend yield anchors total return. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate JOHN WILEY & SONS, INC.'s capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 10.0%, and the balance sheet is managed within acceptable parameters (D/E: 118%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; JOHN WILEY & SONS, INC. falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. The 3.84% dividend yield provides some income return, but the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, JOHN WILEY & SONS, INC. receives a Hold rating with a composite score of 52.5/100 (rank #1607 of 7,333). Our quantitative framework assigns a No Moat (34/100, trend: stable), Medium uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 59/100.
Our analysis supports a neutral stance on JOHN WILEY & SONS, INC.. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign JOHN WILEY & SONS, INC. a meaningful economic moat, scoring 34/100 on our composite assessment. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 18.2/20.
The strongest moat sources are margin superiority (18.2/20) and financial resilience (6.6/20). GM 74% vs sector 43%, OM 13% vs sector 1%. Interest coverage N/A. These pillars form the core of JOHN WILEY & SONS, INC.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and economic value creation (4.1/20). Capital turnover N/A. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect JOHN WILEY & SONS, INC.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 74% providing a solid profitability foundation, operating margins of 13% reflecting effective cost management. The margin cascade from 74% gross to 13% operating to 4.3% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 73th percentile.
The margin profile shows gross margins of 74%, operating margins of 13%, net margins of 4.3%. Return metrics include ROE of 10.0% and ROA of 3.0%. Relative to the Manufacturing sector, gross margins are 31.7 percentage points above the sector median of 43%, and ROE of 10.0% compares to a sector median of -2.5%.
The balance sheet reflects above-average leverage with D/E of 118%, a dividend yield of 3.84%, revenue growth of 4%. The sector median D/E is 0%, putting JOHN WILEY & SONS, INC. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
Virtusa Corporation has entered a multi-year managed services partnership with John Wiley & Sons to provide infrastructure and application services, including taking ownership of Wiley's Sri Lanka technology operation, to support the publisher's long-term technology transformation. This shift effectively outsources a significant part of Wiley's technology backbone, with potential implications for its cost structure, innovation pace, and operational risk profile. We’ll now examine how this...

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday. SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares climbed 87.1% to $3.18 after the company announced it secured a majority stake in True Gold Consortium. PowerFleet, Inc. (NASDAQ: PWFL) gained 42% to $2.80. Powerfleet and MiX Telematics entered into a definitive agreement to form one of the largest mobile asset Internet of Things Software-as-a-Service providers in the world. SaverOne 2014 Ltd (NASDAQ: SVRE) rose 31.1% to $0.7010. Intrusion Inc. (NASDAQ: INTZ) gained 30.4% to $0.4565. Intrusion has been awarded a $5 million agreement with a large telecommunications provider to provide Intrusion Shield support for its data centers. Startek, Inc. (NYSE: SRT) gained 29.1% to $4.21 as the company agreed to be acquired by funds managed by CSP Management Limited for $4.30 per share in cash. CISO Global Inc. (NASDAQ: CISO) shares climbed 29.1% to $0.18. CISO Global said its Argo Edge Cloud Security Platform has been independently valued at $49 million. Mobilicom Limited (NASDAQ: MOB) climbed 27.1% to $1.8050, after gaining more than 11% on Monday. PGT Innovations, Inc. (NYSE: PGTI) surged 21.8% to $31.92. NanoString Technologies, Inc. (NASDAQ: NSTG) gained 20.7% to $1.4506 after the company disclosed third-quarter preliminary results and a reorganization designed to accelerate its path to profitability. Erasca, Inc. (NASDAQ: ERAS) rose 20.6% to $2.6550. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) climbed 19% to $0.2209. MDxHealth SA (NASDAQ: MDXH) gained 18.5% to $2.82. MDxHealth reported preliminary revenues of $19.3 million for the third quarter, representing an increase of 73% year over year. Lexicon Pharmaceuticals, Inc. (NASDAQ:

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some big stocks recording losses in today’s session. Akero Therapeutics, Inc. (NASDAQ: AKRO) shares dipped 63.9% to $17.52 after the company reported a 36-week analysis of its Phase 2b SYMMETRY study evaluating the efficacy and safety of its lead product candidate, efruxifermin. 89bio, Inc. (NASDAQ: ETNB) tumbled 37.7% to $9.68. Ventyx Biosciences, Inc. (NASDAQ: VTYX) fell ...

John Wiley & Sons reported mixed earnings, with sales beating expectations but adjusted earnings missing. The company's research division saw solid growth, but the professional learning division was a drag on results. Wiley provided guidance for fiscal 2025, forecasting sales growth and adjusted earnings growth, but the stock appears expensive given the company's debt load and single-digit growth.
Hyatt Hotels, Unity Software, ParaZero Technologies, and PagerDuty saw their share prices move in out-of-hours trading